Study compares melatonin and tart cherry for sleep aid effects
Melatonin and tart cherry are compared for sleep aid effects in a new study about their benefits.
Featured Stories
All Stories →
Parkinson’s study finds higher amyloid plaques in women’s brains
New Parkinson’s study reveals women’s brains show one of the highest levels of Alzheimer’s-related amyloid plaques compared to men’s brains.
Morning habits that science says boost energy naturally
Science-backed morning habits like hydration and sunlight exposure can naturally boost energy and focus—discover how small changes in your first…
How over-giving in relationships fuels chronic inflammation
Chronic over-giving in relationships may fuel inflammation, even in healthy individuals, according to integrative medicine experts Lissa Rankin and
BP Trends
More →
Diet Links
More →
Monitor Picks
More →
Lyme vaccine fails late-stage trial test
Free Ambulance Service Saves Lives in Yobe State
Stress Checks
More →
Drug Doses
More →
Popular Posts
Refresh ↺Brain Development Peaks in Early Thirties
Brain development peaks in early thirties with significant changes in structural connectivity, according to a recent study on brain network…
Millions Leave Obamacare Due to Fraud Crackdown
Millions leave Obamacare due to fraud crackdown efforts, causing enrollment to decline significantly this year.
Nigeria Confirms Ebola Case in FCT, Activates Response
Nigeria confirms Ebola case in FCT after lab tests verify diagnosis of a female traveler from Uganda. Health authorities activate…
Shingles Vaccine May Reduce Heart Disease Risk
A 2026 study finds the shingles vaccine may lower heart disease risk over a seven‑year period, giving seniors a dual…
New Tribe Seeks Improved Health Services
Lumbee Tribe seeks improved health services, focusing on better healthcare for its citizens through healthy diet and exercise, like Angie…
Risankizumab Outperforms Deucravacitinib in Moderate Plaque Psoriasis
risankizumab psoriasis study shows the drug clears skin in over 50% of moderate plaque patients after 16 weeks, outperforming deucravacitinib…